Project Grant R01HL184443
Award Date 8/15/26
Completion Date 5/31/30
Dollars Obligated $742K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
- The National Institutes of Health National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $759,514 under project grant R01HL180303 on July 25, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient will investigate lung aging in people with HIV, focusing on how chronic antigenic stimulation from viral peptides drives lung inflammation and cellular senescence. The research examines...
- The National Heart, Lung, and Blood Institute awarded Rutgers, The State University of New Jersey (RBHS-School of Nursing) $554,766 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate mechanisms underlying susceptibility to ozone-induced acute respiratory distress syndrome. The research focuses on why only some patients with sepsis develop acute respiratory distress syndrome and how exposure to air pollutants such as ozone exacerbates this...
- The National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey $631,413 on August 1, 2026, as a Project Grant (R01HL183945) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research investigating the role of lipotoxicity-induced splenic cell alternative splicing in obesity cardiomyopathy. The study examines how fatty acid-induced alternative splicing of the BCL2L1 gene in the spleen contributes to the development of obesity...
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey $235,500 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to characterize mechanisms of foam cell formation in tuberculosis and cryptococcosis infections. The recipient, operating as RBHS-School of Nursing, will conduct comparative analysis of pathogen-associated molecular patterns (PAMPs) and macrophage pattern recognition receptors (PRRs)...
- The National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey, School of Nursing, $117,750 on May 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct proteomic profiling and neurocognitive assessment to uncover stroke mechanisms in adults with sickle cell disease. The study quantifies neurodegeneration-associated and mitochondrial proteins in a cohort of 90 sex- and age-matched adults comprising 30 healthy controls, 30...
- The National Institute of General Medical Sciences awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $321,304 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing R35GM162265) to conduct research on the metabolic regulation of innate immunity-dependent wound healing in situ. The research employs zebrafish (Danio rerio) as an in vivo model to dissect multi-cellular interactions during tissue...
- The National Heart Lung and Blood Institute, part of the Department of Health and Human Services National Institutes of Health, awarded $426,250 to the University Of Kansas Medical Center Research Institute, Inc. on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop inhaled BK channel potentiators as a mutation-agnostic treatment for mucus plugging in cystic fibrosis. The recipient will tether R-vanzacaftor to nanosponges as part of a cell-targeting...
- The National Heart, Lung, and Blood Institute awarded Rutgers, The State University $165,613 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a career development project focused on improving vaso-occlusive crisis pain management for sickle cell disease in emergency departments. The award funds Dr. Melinda Rushing's development as an independent investigator in implementation science and health services research. The project proposes a...
- Federal Grant Award Summary Rutgers, The State University received a $235,500 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025 through August 31, 2027. The award funds research to uncover cross-disease platelet transcriptomic signatures that advance precision medicine across cardiovascular, immune-mediated, cancer, and hematologic diseases, including myeloproliferative neoplasms....
- The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey $762,847 on February 3, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the contribution of Type III interferons to the pathogenesis of Staphylococcus aureus infection. The research examines how Type III interferon signaling influences S. aureus pneumonia pathogenesis and bacterial clearance from the airway. The work includes investigation...